Cite
MLA Citation
Sarah C Rutherford et al.. “Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 study.” Lancet, vol. 8, no. 11, 2021, pp. e818–e827. http://access.bl.uk/ark:/81055/vdc_100145482424.0x000003